Johnson & Johnson [JNJ] stock prices are up 1.56% to $155.50 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The JNJ shares have gain 2.39% over the last week, with a monthly amount drifted -6.25%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Johnson & Johnson [NYSE: JNJ] stock has seen the most recent analyst activity on November 15, 2024, when Wolfe Research initiated its Outperform rating and assigned the stock a price target of $190. Previously, Daiwa Securities downgraded its rating to Neutral on July 23, 2024, and dropped its price target to $150. HSBC Securities upgraded its rating to a Buy but stick to its price target of $170 on April 18, 2024. Wells Fargo downgraded its rating to a Equal Weight and reduced its price target to $163 on December 13, 2023. UBS upgraded its rating to Buy for this stock on December 01, 2023, and upped its price target to $180. In a note dated October 05, 2023, RBC Capital Mkts initiated an Outperform rating and provided a target price of $178 on this stock.
The stock price of Johnson & Johnson [JNJ] has been fluctuating between $143.13 and $168.85 over the past year. Currently, Wall Street analysts expect the stock to reach $179.13 within the next 12 months. Johnson & Johnson [NYSE: JNJ] shares were valued at $155.50 at the most recent close of the market. An investor can expect a potential return of 15.2% based on the average JNJ price forecast.
Analyzing the JNJ fundamentals
The Johnson & Johnson [NYSE:JNJ] reported sales of 87.69B for trailing twelve months, representing a surge of 5.27%. Gross Profit Margin for this corporation currently stands at 0.69% with Operating Profit Margin at 0.25%, Pretax Profit Margin comes in at 0.2%, and Net Profit Margin reading is 0.17%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.21 and Total Capital is 0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.51.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 153.52 points at the first support level, and at 151.54 for the second support level. However, for the 1st resistance point, the stock is sitting at 156.77, and for the 2nd resistance point, it is at 158.04.
Ratios To Look Out For
It’s worth pointing out that Johnson & Johnson [NYSE:JNJ]’s Current Ratio is 1.03. Further, the Quick Ratio stands at 0.79, while the Cash Ratio is 0.39. Considering the valuation of this stock, the price to sales ratio is 4.27, the price to book ratio is 5.34 and price to earnings (TTM) ratio is 25.70.
Transactions by insiders
Recent insider trading involved Decker Robert J, VP Corporate Controller, that happened on Aug 30 ’24 when 5635.0 shares were sold. Officer, Decker Robert J completed a deal on Aug 30 ’24 to buy 5635.0 shares. Meanwhile, EVP, Global Corp Affairs Broadhurst Vanessa sold 8891.0 shares on Mar 13 ’24.
